|
Continuation of d10: 5086mri58 lead, implanted: (b)(6) 2012, 6935m62 lead, implanted: (b)(6) 2017, medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
It was reported by the patient that following a revision procedure, they called and asked why a new lead had been implanted and whether the previous lead was defective.The patient stated that the physician discussed high impedance, possible fibrosis, and that the replacement lead was placed in a different location.The left ventricular (lv) lead was capped and replaced.No patient complications have been reported as a result of this event.
|